Back to calendar
Viridian Therapeutics, Inc. (VRDN) Earnings
VRDN reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026
Q2 2026
Est. EPS: $-0.99
Actual EPS: $-1.05
EPS surprise: -1.48%
Company overview
Market Cap$2.6B
PriceUSD 23.37
EPS (TTM)-3.71
52-week high34.29
52-week low13.18
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees252